Levels Of Pregnancy-Associated Plasma Protein A In Patients With Coronary Artery Disease

Zhi-Yuan Liu,Jin-Ying Zhang,Tong-Wen Sun,Yan-Jun Zhang,Li Zhang,Le-Xin Wang

DOI: https://doi.org/10.25011/cim.v31i2.3368

2008-01-01

Abstract:Purpose: To investigate the levels of pregnancy-associated plasma protein A (PAPP-A) or insulin-like growth factor-1 (IGF-1) in patients with acute coronary syndrome.Methods: Serum PAPP-A and IGF-1 was measured with biotin-tyramide-amplified enzyme immunoassay and Enzyme Linked Immuoserbent Assay, respectively, in patients with ST elevation acute myocardial infarction (STEMI, n=12), unstable angina (UAP, n=15), and stable angina (n=15). PAPP- A and IGF-1 was also measured in 16 healthy subjects ( control group).Results: The serum levels of PAPP-A in the STEMI (16.9 +/- 10.3 mIU/L) and UAP group (15.2 +/- 10.5 mIU/L) were higher than in the stable angina (8.5 +/- 3.1 mIU/L) or control group (8.4 +/- 2.0 mIU/L, P<0.01). The serum levels of IGF-1 in the STEMI (132.3 +/- 40.9 mu g/L) and UAP group (127.3 +/- 36.0 mu g/L) were also higher than in the stable angina (44.9 +/- 18.5 mu g/L) or control group (67.7 +/- 24.5 mu g/L, P<0.01). There were no differences in serum levels of PAPP-A or IGF- 1 among the single, double and three vessel lesion groups. The serum levels of PAPP- A (19.9 +/- 10.1 mIU/L) and IGF- 1 (153.2 +/- 52.4 mu g/L) after PCI were higher than those before PCI (15.1 +/- 10.0 mIU/ L and 91.4 +/- 51.0 mu g/L, respectively, P< 0.01). A positive correlation was found between PAPP- A and IGF- 1 levels in the STEMI and UAP group before PCI (r=0.48, P<0.01).Conclusion: PAPP-A and IGF-1 are elevated in patients with acute coronary syndrome. They may be used as bio-markers for vulnerable plaques in patients with coronary artery disease. Whether post-PCI elevation of IGF-1 can be used to predict restenosis of coronary arteries remains to be seen.